ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
Author(s) -
Kimberly C. Wiegand,
Sohrab P. Shah,
Osama M. AlAgha,
Yongjun Zhao,
Kane Tse,
Thomas Zeng,
Janine Senz,
Melissa K. McConechy,
Michael S. Anglesio,
Steve E. Kalloger,
Winnie Yang,
Alireza HeraviMoussavi,
Ryan Giuliany,
Christine Chow,
John Fee,
Abdalnasser Zayed,
Leah Prentice,
Nataliya Melnyk,
Gulisa Turashvili,
Allen Delaney,
Jason Madore,
Stephen Yip,
Andrew McPherson,
Gavin Ha,
Lynda Bell,
Sián Fereday,
Angela Tam,
Laura Galletta,
Patricia N. Tonin,
Diane Provencher,
Dianne Miller,
Steven J.M. Jones,
Richard A. Moore,
Gregg B. Morin,
Arusha Oloumi,
Niki Boyd,
Samuel Aparício,
Ie Ming Shih,
AnneMarie MesMasson,
David D.L. Bowtell,
Martin Hirst,
C. Blake Gilks,
Marco A. Marra,
David G. Huntsman
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1008433
Subject(s) - arid1a , clear cell carcinoma , clear cell , cancer research , ovarian cancer , serous fluid , endometriosis , carcinoma , medicine , somatic cell , tumor suppressor gene , pathology , biology , mutation , cancer , carcinogenesis , gene , genetics
Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom